Effects of Helicobacter pylori gastritis on gastric secretion in healthy human beings

被引:45
作者
Feldman, M
Cryer, B
Lee, E
机构
[1] Vet Affairs Med Ctr, Med Serv, Dallas, TX 75216 USA
[2] Vet Affairs Med Ctr, Lab Serv, Dallas, TX 75216 USA
[3] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75216 USA
[4] Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75216 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 1998年 / 274卷 / 06期
关键词
gastric acidity; pepsin activity; serum gastrin; nonparietal secretion; pentagastrin;
D O I
10.1152/ajpgi.1998.274.6.G1011
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Helicobacter pylori gastritis is common, but effects on gastric secretion are not well understood. We measured basal and pentagastrin-stimulated gastric acidity, pepsin activity, and fluid output, as well as serum gastrin concentrations and H. pylori antibody levels, before and after treatment of H. pylori gastritis in 28 men and women. Subjects were studied before and 1 and 3 mo after a course of bismuth, metronidazole, and tetracycline. Elimination of H. pylori gastritis, accomplished in 14 subjects, increased basal and pentagastrin-stimulated gastric acidity (by 15 meq/l) and basal acid output significantly (by 2.1 meq/h 1 mo after therapy). Elimination of H. pylori had an opposite effect on pepsin secretion, significantly decreasing pepsin output by 30%. Elimination of H. pylori significantly reduced nonparietal fluid output by 35%, without affecting fluid output from parietal cells. Serum gastrin and H. pylori antibody levels declined significantly after elimination of H. pylori. None of these changes was observed in 14 subjects whose H. pylori gastritis was resistant to antimicrobial therapy. In summary, eradication of H. pylori infection increases gastric acidity by reducing nonparietal gastric secretion from peptic and other cells.
引用
收藏
页码:G1011 / G1017
页数:7
相关论文
共 41 条
[1]   HELICOBACTER-PYLORI AND LUMINAL GASTRIC PH - RELATIONSHIPS IN NONULCER DYSPEPSIA [J].
BECHI, P ;
DEI, R ;
AMOROSI, A ;
MARCUZZO, G ;
CORTESINI, C .
DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (03) :378-384
[2]  
BEHOLZ S, 1989, AM J GASTROENTEROL, V84, P201
[3]   OMEPRAZOLE ENHANCES EFFICACY OF TRIPLE THERAPY IN ERADICATING HELICOBACTER-PYLORI [J].
BORODY, TJ ;
ANDREWS, P ;
FRACCHIA, G ;
BRANDL, S ;
SHORTIS, NP ;
BAE, H .
GUT, 1995, 37 (04) :477-481
[4]   EFFECT OF HELICOBACTER-PYLORI ON PARIETAL-CELL SENSITIVITY TO PENTAGASTRIN IN DUODENAL-ULCER SUBJECTS [J].
CHITTAJALLU, RS ;
HOWIE, CA ;
MCCOLL, KEL .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1992, 27 (10) :857-862
[5]   Gastric mucosal biopsy via a nasogastric tube: A nonendoscopic method for diagnosing fundic and antral mucosal gastritis and Helicobacter pylori infection in man [J].
Cryer, B ;
Lee, E ;
Feldman, M .
GASTROINTESTINAL ENDOSCOPY, 1996, 44 (03) :317-323
[6]   EFFECT OF ACID SUPPRESSION ON EFFICACY OF TREATMENT FOR HELICOBACTER-PYLORI INFECTION [J].
DEBOER, W ;
DRIESSEN, W ;
JANSZ, A ;
TYTGAT, G .
LANCET, 1995, 345 (8953) :817-820
[7]   ERADICATING HELICOBACTER-PYLORI INFECTION LOWERS GASTRIN MEDIATED ACID-SECRETION BY 2/3 IN PATIENTS WITH DUODENAL-ULCER [J].
ELOMAR, E ;
PENMAN, I ;
DORRIAN, CA ;
ARDILL, JES ;
MCCOLL, KEL .
GUT, 1993, 34 (08) :1060-1065
[8]   Helicobacter pylori infection and chronic gastric acid hyposecretion [J].
ElOmar, EM ;
Oien, K ;
ElNujumi, A ;
Gillen, D ;
Wirz, A ;
Dahill, S ;
Williams, C ;
Ardill, JES ;
McColl, KEL .
GASTROENTEROLOGY, 1997, 113 (01) :15-24
[9]   HELICOBACTER-PYLORI INFECTION AND ABNORMALITIES OF ACID-SECRETION IN PATIENTS WITH DUODENAL-ULCER DISEASE [J].
ELOMAR, EM ;
PENMAN, ID ;
ARDILL, JES ;
CHITTAJALLU, RS ;
HOWIE, C ;
MCCOLL, KEL .
GASTROENTEROLOGY, 1995, 109 (03) :681-691
[10]   GASTRIC BICARBONATE SECRETION IN HUMANS - EFFECT OF PENTAGASTRIN, BETHANECHOL, AND 11,16,16-TRIMETHYL PROSTAGLANDIN-E2 [J].
FELDMAN, M .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (01) :295-303